HIV disease: a review for the family physician. Part II. Secondary infections, malignancy and experimental therapy
- PMID: 2173387
HIV disease: a review for the family physician. Part II. Secondary infections, malignancy and experimental therapy
Abstract
The first part of this two-part article included recommendations for the initial evaluation of patients suspected of having HIV infection, the Centers for Disease Control's classification scheme for HIV disease and current recommendations for the use of zidovudine. In this second part, secondary infections and malignancy are reviewed, and various experimental therapies are briefly discussed.
Similar articles
-
Pulmonary disease in patients with human immunodeficiency virus infection.Dan Med Bull. 1989 Oct;36(5):503-6. Dan Med Bull. 1989. PMID: 2553341 Review.
-
Retinal manifestations of the acquired immune deficiency syndrome (AIDS): cytomegalovirus, candida albicans, cryptococcus, toxoplasmosis and Pneumocystis carinii.Trans Ophthalmol Soc U K (1962). 1983;103 ( Pt 2):177-90. Trans Ophthalmol Soc U K (1962). 1983. PMID: 6320505
-
[Clinical aspects of HIV-associated diseases].Ther Umsch. 1988 Sep;45(9):604-10. Ther Umsch. 1988. PMID: 2847345 German. No abstract available.
-
[Opportunistic diseases in patients with HIV infection].Schweiz Rundsch Med Prax. 1986 Nov 25;75(48):1445-50. Schweiz Rundsch Med Prax. 1986. PMID: 3025990 German. No abstract available.
-
Prophylaxis of AIDS-related opportunistic infections (OIs).AIDS Clin Rev. 1989:125-50. AIDS Clin Rev. 1989. PMID: 2562216 Review. No abstract available.
Cited by
-
Drug development in targeting ion channels for brain edema.Acta Pharmacol Sin. 2020 Oct;41(10):1272-1288. doi: 10.1038/s41401-020-00503-5. Epub 2020 Aug 27. Acta Pharmacol Sin. 2020. PMID: 32855530 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical